The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Direct effects of the selective CYP17 lyase (L) inhibitor, VT-464, on the androgen receptor (AR) and its oral activity in an F876L tumor mouse xenograft model.
 
William R. Moore
Employment - Inimex
Leadership - Innocrin Pharma
Stock and Other Ownership Interests - Innocrin Pharma
 
John D. Norris
Research Funding - Viamet Pharmaceuticals (Inst)
 
Suzanne Wardell
Consulting or Advisory Role - Pfizer (Inst)
Research Funding - Pfizer (Inst); Viamet Pharmaceuticals (Inst)
 
Joel Robert Eisner
Employment - Innocrin Pharma
Stock and Other Ownership Interests - Innocrin Pharma
 
William J. Hoekstra
Employment - Viamet Pharmaceuticals
Stock and Other Ownership Interests - Viamet Pharmaceuticals
 
Robert J. Schotzinger
Employment - Viamet Pharmaceuticals
Leadership - Viamet Pharmaceuticals
Stock and Other Ownership Interests - Viamet Pharmaceuticals
 
Donald P. McDonnell
Consulting or Advisory Role - Advinus (Inst); Pfizer (Inst); Radius Health (Inst)
Research Funding - Advinus (Inst); Novartis (Inst); Pfizer (Inst); Radius Health (Inst); Viamet Pharmaceuticals (Inst)